| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer
1 company
Isacson Christina K. is a Chief Business Officer at Dianthus Therapeutics, Inc. /DE/. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $6.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 24, 2019 | DNTH Dianthus Therapeutics, Inc. /de/ | Chief Business Officer | Sell | 4,463 | $16.01 | $71,452.63 | -5.1% | |
| Dec 23, 2019 | DNTH Dianthus Therapeutics, Inc. /de/ | Chief Business Officer | Sell | 9,867 | $16.03 | $158,168.01 | -10.1% | |
| Jun 21, 2019 | DNTH Dianthus Therapeutics, Inc. /de/ | Chief Business Officer | Sell | 5,415 | $16.07 | $87,019.05 | -5.2% |